Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • OUTLOOK

The global fight against hepatitis B is benefitting some parts of the world more than others

Cartoon of two figures on a see-saw that is made of a hypodermic needle

Illustration: Chiara Zarmati

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Nature 603, S58-S59 (2022)

doi: https://doi.org/10.1038/d41586-022-00818-9

This article is part of Nature Outlook: Hepatitis B, an editorially independent supplement produced with the financial support of third parties. About this content.

References

  1. Stockdale, A. J. et al. J. Infect. Dis. https://doi.org/10.1093/infdis/jiab562 (2021).

    Article  Google Scholar 

  2. Kane, M. A. et al. Vaccine 31, J15–J20 (2013).

    Article  PubMed  Google Scholar 

  3. Qu, C., Duan, Z., Chen, K. & Zou, H. Hepatoma Res. 3, 228–240 (2017).

    Article  Google Scholar 

  4. Tordrup, D. et al. Lancet Glob. Health 7, e1180-e1188 (2019).

    Article  PubMed  Google Scholar 

  5. Tordrup, D. et al. Value Health 23, 1552–1560 (2020).

    Article  PubMed  Google Scholar 

  6. Toy, M., Hutton, D. W. & So, S. Health Aff. 37, 1033–1040 (2018).

    Article  Google Scholar 

  7. Toy, M. et al. Clin. Infect. Dis. 74, 210–217 (2022).

    Article  PubMed  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links